AzTrials
AzTrials

DementiaSONNETNCT05315960

SOcial coNNEction in Long-Term Care Home Residents

An observational study of Dementia, run by University College, London at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to develop a new measure which can accurately assess social connection for people with dementia living in long-term care homes. The Social Connection in Long-term Care home residents (SONNET) study will use interviews and focus groups with people affected by dementia and long-term care residents to… Read more about this study

Who is it for?
Ages 18 to 110 yearsHealthy volunteers can take part
Conditions the study is for
Dementia
How many people
220 participants
Where
2 sitesin 2 countries
Study dates
16 May 2022to 30 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 110 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study will purposively sample participants for diverse representation, including with respect to age, sex, gender identity, sexual orientation, socioeconomic status, race, ethnicity, and, marital status. To ensure a range of demographic characteristics and to include traditionally under-represented groups, English language proficiency for people living with dementia, LTC residents and caregivers (e.g. family, friend) is not a requirement. Interpreters will be used for those not fluent in English and arranged through the institution's interpreter services.

Who may be able to join

  • LTC residents with or without dementia: Able to provide consent for research.
  • Caregivers: Visit the resident at least monthly (not including when COVID-related visitor restrictions are in place).
  • Clinicians/care staff: Whose role currently includes working in LTC home or has done in past 2 years.
  • Academic researchers: Have expertise in social functioning in dementia.
  • All participants must be over the age of 18 years old to participate in the study.
  • Cross-sectional study Inclusion criteria
Show all 9Show fewer
  • LTC residents: Have a confirmed diagnosis of dementia OR Scoring ≥2 on the Noticeable Problems Checklist
  • Proxy: Visit or care for the resident at least once monthly.
  • All participants must be over the age of 18 years old and have adequate English language proficiency to participate in the study.

Who cannot join

None listed.

Trial locations and contacts

2 sites in 2 countries.

Andrew Sommerlad contact

+442076799248

a.sommerlad@ucl.ac.uk

Jennifer Bethell contact

jennifer.bethell@uhn.ca

2 sites in 2 countries

Canada1 site, 1 recruiting
  • University Health Network

    Toronto, Ontario, M5G 2A2

    Jennifer Bethell, jennifer.bethell@uhn.ca

    Not yet recruiting

Other trials in Canada

United Kingdom1 site, 1 recruiting
  • Division of Psychiatry, University College London

    London, W1T 7NF

    Andrew Sommerlad, a.sommerlad@ucl.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

This study aims to develop a new measure which can accurately assess social connection for people with dementia living in long-term care homes. The Social Connection in Long-term Care home residents (SONNET) study will use interviews and focus groups with people affected by dementia and long-term care residents to establish what aspects of social connection are important for people living in care homes. These findings and a review of other studies and measures will be used to develop a new measure or measures of social connection which will then be tested in a study based in care homes in Canada and the UK.

Read the detailed description

Research Question:

Can a new measure reliably and validly assess social connection for people with dementia in care homes?

Background:

Social connection, including objective and subjective constructs relating to human relationships, is a fundamental human need, but is impaired in people with dementia, particularly in those living in long-term care (LTC) settings due to cognitive impairment, complex health needs, and separation from previous social networks and community activities. Measurement instruments therefore need to be tailored to the distinct characteristics of this population and be tested in this setting, but there is no current evidence-based consensus on the best approaches to measurement.

Objectives:

  1. Appraise existing measures of social connection used in LTC homes
  2. Evaluate which aspects of social connection are considered important by people affected by dementia and professional staff
  3. Develop a new measure informed by our appraisal of previous measures and the priorities of key stakeholders and test its preliminary psychometric properties

Methods:

A systematic review of measurement instruments assessing social connection in LTC residents, including dementia-specific measures will be conducted and measures will be appraised using COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) methodology. Focus groups and qualitative interviews will then be conducted with 50-70 people living with dementia, LTC residents, families, clinicians, care staff, and researchers in the UK and Canada to establish the important aspects of social connection and its measurement, including considerations for LTC residents with dementia and those with different stages of dementia severity. Findings from the systematic review and qualitative study will be used to inform the development of a measure or measures which will be iteratively refined during interviews. Finally, the new measure(s) will be tested for psychometric properties in 150 people with dementia living in LTC homes in the UK and Canada to establish acceptability, reliability, and validity.

Conditions
Dementia
Keywords
Dementia, Long-term care, Outcome measurement, PROM, Psychometric
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05315960
Study groupRoleWhat they receive
Qualitative studyConsenting participants will complete a form asking about basic characteristics including age, sex, ethnicity, marital status etc. People living in long-term care and family carers will participate in an individual interview and professional staff will participate in an individual interview or focus group (between 5 and 10 participants) depending on their preference. The interview or focus group is expected to last 30-60 minutes. Sessions will be conducted in-person or online (using MS Teams), depending on preference and COVID-19-related restrictions. All sessions will be audio-recorded and transcribed.
Cross-sectional studyProcedures: Consent will be obtained from residents, for those who have mental capacity to give informed consent, or from a nearest relative or caregiver as consultee, for those who lack capacity. Once consent is obtained, the LTC resident will be asked to complete a form asking about their characteristics and a questionnaire about their social connections which is expected to take approximately 15 minutes. The proxy will be asked to complete a sociodemographic form about themselves along with a number of questionnaires regarding the LTC resident's dementia severity, neuropsychiatric symptoms, activities of daily living and quality of life for comparison. Data collection for the proxy is expected to take approximately 30-60 minutes. Anticipated sample size 150 between Canada and the UK.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resident Assessment Instrument-Minimum Data Set (RAI-MDS) Index of Social Engagement

    Minimum 0, Maximum 6. Higher scores indicate a higher level of social engagement.

    Measured: 10 minutes

Secondary outcomes (5)
  1. Clinical Dementia Rating Scale

    Minimum 0, Maximum 5. Higher scores indicate a more severe dementia.

    Measured: 10 minutes

  2. Neuropsychiatric Inventory

    Minimum 0, Maximum 144. Higher scores indicate a more severe neuropsychiatric symptoms.

    Measured: 10 minutes

  3. Katz Index of Independence in activities of Daily Living

    Minimum 0, Maximum 6. Higher scores indicate more independence in activities in daily living.

    Measured: 10 minutes

  4. Dementia-specific quality of life (DEMQOL-Proxy)

    Minimum 31, Maximum 124. Higher scores indicate better health-related quality of life.

    Measured: 10 minutes

  5. Family caregiver proxy-raters only will also be asked to completed the EQ5D

    Minimum 0, Maximum 1. Higher scores indicate better quality of life.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2022
  2. Study start16 May 2022
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05315960
Sponsor's protocol ID
146256
Acronym
SONNET
Status last verified
Nov 2023
First submitted
18 Mar 2022
Last updated
30 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Chapman H, Bethell J, Dewan N, Liougas MP, Livingston G, McGilton KS, Sommerlad A. Social connection in long-term care homes: a qualitative study of barriers and facilitators. BMC Geriatr. 2024 Oct 22;24(1):857. doi: 10.1186/s12877-024-05454-8.

    PubMed 39438797

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia, run by University College, London at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrew Sommerlad (+442076799248, a.sommerlad@ucl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resident Assessment Instrument-Minimum Data Set (RAI-MDS) Index of Social Engagement (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05315960, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in